Dr. Ashwini Zenooz will lead the Life Sciences and Healthcare sector, overseeing BIOVIA, MEDIDATA and ArisGlobal. Dassault Systèmes announced it has completed the acquisition of ArisGlobal and is now uniting its Life Sciences and Healthcare capabilities into a unified AI…
Boost ROI by outsourcing preclinical testing to cut costs and timelines, while using AI, automation, in silico models and organ-on-chip platforms to improve accuracy. Dublin, Oct. 27, 2026 (GLOBE NEWSWIRE) -- "Preclinical Contract Research Organizations - Global Strategic Business Report" has been added to…
Alcon has acquired Neurotech Pharmaceuticals for $550 million, expanding its retina portfolio with ENCELTO, the first and only U.S. FDA-approved treatment for adults with idiopathic Macular Telangiectasia Type 2, or MacTel. Neurotech Pharmaceuticals is focused on developing cell therapies for chronic and neurodegenerative…
The CMS (contract manufacturing solutions) division manufactures APIs and intermediates, but for innovator companies that are in the clinical testing phase or have commercialised the products. As on June 30, 2026, the company had 99 projects in the division across commercial (19), pre-registration (7) and…
Lower valuations, corporate carve-outs and resilience to AI disruption are opening up medtech to buyout firms after years of limited access. Gainline Capital upsizes target for Fund III 1 hour ago · 2 mins read LACERA to reduce meeting frequency despite governance concerns…
Alcon will add the first and only FDA approved treatment for macular telangiectasia type 2 to its retina portfolio. MacTel is a rare, progressive neurodegenerative disease that causes irreversible loss of central vision, and until Encelto it had no approved treatment.
Alcon’s Neurotech Pharmaceuticals acquisition brings the rare vision disorder cell therapy Encelto as well as the platform technology that developed it. Last year, Alcon acquired a majority stake in Aurion Biotech, a startup developing a corneal cell therapy. Vision products…
The business makes single-use bioprocessing products, including Aramus and PE bags, used from drug discovery through commercial manufacturing. A verification email is on its way to you. Please check your spam or junk folder just in case. Need help signing…
Sciontec Developments Limited (Sciontec)’s flexible workspace portfolio is in high demand, following an influx of new customers and pre-let negotiations for HEMISPHERE. Following a 38% increase in deals year on year, demand for Sciontec’s Liverpool city centre-based laboratory and office…
The latest VC funding deals include announcements from XRlabs, Cellbox Solutions, VECKTA, Playground Global, Eka Ventures, and others. VC funding deals: XRlabs, Cellbox Solutions, VECKTA The latest VC funding deals include announcements from XRlabs, Cellbox Solutions, VECKTA, Playground Global, Eka…
Biotech acquisitions: drugmakers buying biotechs, biotech mergers, deal sizes and what the takeovers say about the market.
An article joins this feed when it matches these terms. Each one is also a search of its own.